1. Wallace et al., Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting, Molecular Therapy (2024), https://doi.org/10.1016/j.ymthe.2024.01.010.
2. Strong, R.K., Holmes, M.A., Li, P., Braun, L., Lee, N., and Geraghty, D.E. (2003). HLA-E Allelic Variants correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278, 5082–5090.
3. Sauter, J., Putke, K., Schefzyk, D., Pruschke, J., Solloch, U.V., Bernas, S.N., Massalski, C., Daniel, K., Klussmeier, A., Hofmann, J.A., et al. (2021). HLA-E typing of more than 2.5 million potential hematopoietic stem cell donors: Methods and population-specific allele frequencies. Hum. Immunol. 82, 541–547.